ClassID:

93453

C07C311/39 - CPC Classification

Classification description:

Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups; Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom

Sub-classes:
Recent Application in this class:
#1
20260132103
2026-05-14

Bumetanide Derivatives for the Therapy of Stroke and Other Neurological Diseases/Disorders Involving NKCCs

#2
20250339388
2025-11-06

PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF

#3
20250319046
2025-10-16

PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF

#4
20250296909
2025-09-25

NOVEL BENZENE DERIVATIVE AND IMMUNOSUPPRESSION-RELATED USE THEREOF

#5
20240409508
2024-12-12

SULFINYLAMINOBENZAMIDE AND SULFONYLAMINOBENZAMIDE DERIVATIVES

#6
20240400501
2024-12-05

3,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF

#7
20240009153
2024-01-11

BUMETANIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

#8
20230174470
2023-06-08

COMPOUND AS A UBR BOX DOMAIN LIGAND

#9
20230174465
2023-06-08

COMPOUND AS A UBR BOX DOMAIN LIGAND

#10
20220402866
2022-12-22

3,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF

#11
20220289673
2022-09-15

WDR5-MYC INHIBITORS

#12
20220281812
2022-09-08

BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF

#13
20220204485
2022-06-30

Stabilization of amyloidogenic immunoglobulin light chains

#14
20220184008
2022-06-16

MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION

#15
20220071935
2022-03-10

BUMETANIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

#16
20220055985
2022-02-24

Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives

#17
20210317076
2021-10-14

COMPOUNDS WITH ANTIMICROBIAL ACTIVITY

#18
20210188763
2021-06-24

COMPOUNDS AND METHODS FOR HEMATOPOIETIC REGENERATION

#19
20210163406
2021-06-03

Bumetanide Derivatives for the Therapy of Stroke and Other Neurological Diseases/Disorders Involving NKCCs

#20
20210094909
2021-04-01

3-(benzylamino)-4-(cyclohexylamino)-n-(2-(piperazin-1-yl)ethyl)benzenesulfonamide derivatives and related ferrostatin-1 analogues as cell death inhibitors for treating e.g. stroke

#21
20200347010
2020-11-05

Compounds with antimicrobial activity

#22
20190359565
2019-11-28

Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives

#23
20190292132
2019-09-26

Compounds and methods for hematopoietic regeneration

#24
20190177270
2019-06-13

M-phenylenediamine compound and method for producing polymer compound using same

#25
20190151263
2019-05-23

BUMETANIDE ANALGOS, COMPOSITIONS, AND METHODS OF USE

#26
20190144450
2019-05-16

Modulators of ATP-binding cassette transporters

#27
20190047947
2019-02-14

3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof

#28
20180002278
2018-01-04

Bis(sulfonamide) derivatives and their use as mPGES inhibitors

#29
20170362172
2017-12-21

Compositions and methods relating to the treatment of cancer, autoimmune disease, and neurodegenerative disease

#30
20170349544
2017-12-07

Ethynylbenzene derivatives

#31
20170313672
2017-11-02

Bis(sulfonamide) derivatives and their use as mPGES inhibitors

#32
20170313653
2017-11-02

3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death

#33
20170217882
2017-08-03

Antivirals against molluscum contagiosum virus

#34
20160318931
2016-11-03

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#35
20150266900
2015-09-24

Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase

#36
20150239832
2015-08-27

ANALOGS AND PRODRUGS OF LOOP DIURETICS, INCLUDING BUMETANIDE, FUROSEMIDE AND PIRETANIDE; COMPOSITIONS AND METHODS OF USE

#37
20150224108
2015-08-13

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

#38
20150218088
2015-08-06

Meta-Diarylaniline or meta-diarylpyridinamine compound, preparation method and medical uses thereof

#39
20150080350
2015-03-19

Bumetanide analogs, compositions and methods of use

#40
20140343315
2014-11-20

Modulators of ATP-binding cassette transporters

#41
20140303026
2014-10-09

Compounds for modulating integrin CD11B/CD18

#42
20140206875
2014-07-24

Compound for inhibiting 11β-hydroxy steroid dehydrogenase 1, and a pharmaceutical composition comprising the same

#43
20140128469
2014-05-08

DEUTERATED N-BUTYL BUMETANIDE

#44
20140094455
2014-04-03

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

#45
20140066504
2014-03-06

ANALOGS AND PRODRUGS OF BUMETANIDE; COMPOSITIONS AND METHODS OF USE

#46
20140018325
2014-01-16

HIV protease inhibitors

#47
20130231323
2013-09-05

Ethynylbenzene derivatives

#48
20130224870
2013-08-29

Solid phase fluorescence labeling reagents and uses thereof

#49
20130096105
2013-04-18

Arylsulfonamide based matrix metalloprotease inhibitors

#50
20130045967
2013-02-21

Compounds for modulating integrin CD11b/CD18

#51
20130035327
2013-02-07

Modulators of ATP-binding cassette transporters

#52
20120258954
2012-10-11

Arylsulfonamide based matrix metalloprotease inhibitors

#53
20120234721
2012-09-20

DIURETIC AND DIURETIC-LIKE COMPOUND ANALOGS

#54
20120156793
2012-06-21

Fluorophore and fluorescent sensor compound containing same

#55
20120149909
2012-06-14

-substituted--phenylethylsulfonamides for the identification of biological and pharmacological activity

#56
20120122920
2012-05-17

LIBRARIES OF N-SUBSTITUTED-N-PHENYLETHYLSULFONAMIDES FOR DRUG DISCOVERY

#57
20120122710
2012-05-17

LIBRARIES OF N-SUBSTITUTED-N-PHENYLETHYLSULFONAMIDES FOR THE IDENTIFICATION OF BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY

#58
20120095024
2012-04-19

TOLUIDINE SULFONAMIDES AND THEIR USE

#59
20120004225
2012-01-05

BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

#60
20110213029
2011-09-01

3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands

#61
20110190302
2011-08-04

Aryl-phenyl-sulfonamide-phenylene compounds and their use

#62
20110172195
2011-07-14

AQUAPORIN MODULATORS AND METHODS OF USING THEM FOR THE TREATMENT OF EDEMA AND FLUID IMBALANCE

#63
20110152261
2011-06-23

Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists

#64
20110014186
2011-01-20

Arylsulfonamide-based matrix metalloprotease inhibitors

#65
20100331321
2010-12-30

Bis-(sulfonylamino) derivatives for use in therapy

#66
20100267945
2010-10-21

Amine derivative having NPY Y5 receptor antagonistic activity

#67
20100210603
2010-08-19

NOVEL SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE

#68
20100063027
2010-03-11

Amine derivative having NPY Y5 receptor antagonistic activity

#69
20100056528
2010-03-04

Sulfonamide derivatives with therapeutic indications

#70
20100056503
2010-03-04

Compounds for modulating integrin CD11b/CD18

#71
20100035898
2010-02-11

Organic compounds

#72
20090306079
2009-12-10

3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

#73
20090298876
2009-12-03

Modulators of ATP-binding cassette transporters

#74
20090227797
2009-09-10

Modulators of ATP-binding cassette transporters

#75
20090163586
2009-06-25

Bis-(Sulfonylamino) Derivatives in Therapy 205

#76
20080293727
2008-11-27

Novel sulfonamide inhibitors of aspartyl protease

#77
20080262096
2008-10-23

Squaric Acid Derivatives

#78
20080262086
2008-10-23

SUBSTITUTED ANTHRANILIC ACIDS

#79
20080234491
2008-09-25

Process for preparation of celecoxib

#80
20080221169
2008-09-11

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

#81
20080071095
2008-03-20

Modulators of ATP-binding cassette transporters

#82
20070213330
2007-09-13

Inhibitors of histone deacetylase

#83
20070149526
2007-06-28

Diuretic and diuretic-like compound analogs

#84
20070122367
2007-05-31

Resorcinol derivatives

#85
20070021494
2007-01-25

3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

#86
20060189810
2006-08-24

Sulfonamide inhibitors of aspartyl protease

#87
20060183944
2006-08-17

Process for preparing reverse transcriptase inhibitors

#88
20060166990
2006-07-27

Aminobenzophenone compounds

#89
20060084641
2006-04-20

IL-8 receptor antagonists

#90
20060074075
2006-04-06

Modulators of ATP-binding cassette transporters

#91
20060030599
2006-02-09

Sulphonamide derivatives

#92
20060014644
2006-01-19

Phenylsulfonyl ureas, process for their preparation and their use as herbicides and plant growth regulators

#93
20050282899
2005-12-22

Resorcinol derivatives

#94
20050256191
2005-11-17

Nitroaniline-based alkylating agents and their use as prodrugs

#95
20050245518
2005-11-03

Inhibitors of histone deacetylase

#96
20050244812
2005-11-03

Kits and methods for detection of apoptotic cells

#97
20050227982
2005-10-13

Antileishmanial dinitroaniline sulfanomides with activity against parasite tubulin

#98
20050222412
2005-10-06

Peptide deformylase inhibitors

#99
20050075507
2005-04-07

1,2,4-Triazole derivative, method for preparing the same, and pharmaceutical composition containing the same

#100
19062521
2025-09-30

Phenylalanine-based LAT1 inhibitors and uses thereof